Anita Afzali

8PUBLICATIONS
55CO-AUTHORS
Forest health and pathologyPlanning and decision makingToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 01, 2026
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial.

|Feb 10, 2026
Artificial Intelligence for Gastroenterology Practice: A Modified Delphi Consensus.

Seth A Gross, Aasma Shaukat, Anita Afzali

|Feb 01, 2025
Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis-A Safety Analysis.

Anita Afzali, Miguel Regueiro, Andres J Yarur

|Jan 08, 2025
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial.

Bruce E Sands, David T Rubin, Edward V Loftus

|Jul 17, 2023
Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States.

Anita Afzali, Rina Lukanova, Fritha Hennessy

|Dec 15, 2022
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial.

Jordan Axelrad, Millie Long, Sara Horst

Pageof 2

Frequent Collaborators

2 joint publications

Sara N Horst

2 joint publications

Miguel Regueiro

2 joint publications

Bruce E Sands

1 joint publications

Jordan Axelrad